Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Montag A & Associates Inc.

Montag A & Associates Inc. cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.5% during the fourth quarter, HoldingsChannel reports. The firm owned 16,429 shares of the medical equipment provider’s stock after selling 3,235 shares during the quarter. Montag A & Associates Inc.’s holdings in Intuitive Surgical were worth $8,575,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. M.E. Allison & CO. Inc. purchased a new stake in Intuitive Surgical during the 4th quarter worth about $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management lifted its stake in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Finally, Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Up 0.7 %

NASDAQ ISRG opened at $595.55 on Friday. The stock has a market capitalization of $212.12 billion, a price-to-earnings ratio of 92.91, a PEG ratio of 5.67 and a beta of 1.39. The business’s 50 day moving average is $559.48 and its two-hundred day moving average is $519.06. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Insider Activity at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock worth $3,587,582 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.